SP

Spinifex Pharmaceuticals

Acquired

Melbourne, Australia · Founded 2005 · $66.5M raised

Headquarters
Melbourne
Founded
2005
Business Model
B2B
Total Funding
$66.5M
Last Round
$45.0M Series CApr 2014
Rounds
3
Acquired by
Novartis AGJun 2015

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Spinifex Pharmaceuticals was a development-stage biopharmaceutical company founded in 2005 out of the University of Queensland, developing non-opioid treatments for chronic neuropathic pain. Its lead candidate, EMA401, was an oral angiotensin II type 2 receptor antagonist designed to block pain signals without central nervous system side effects. Novartis acquired the company in 2015 for roughly US$200 million upfront plus milestone payments, one of the largest venture-backed biotech exits in Australian history.

Summary

Spinifex Pharmaceuticals is a Biotech company based in Melbourne, Australia, founded in 2005. It has raised $66.5M in total across 3 rounds, most recently a $45.0M Series C round in Apr 2014. Investors include Novo Holdings A/S, Uniseed and Brandon Capital Partners.

Funding History

AcquisitionJun 2015

Sign up to see all 4 events

Funding: Series A through Series C. Amounts, valuations, and investors where available.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Spinifex Pharmaceuticals on Indexed.vc
<a href="https://indexed.vc/companies/spinifex-pharmaceuticals"><img src="https://indexed.vc/api/badge/company/spinifex-pharmaceuticals" alt="Spinifex Pharmaceuticals on Indexed.vc" width="260" height="76" /></a>